Bunge Limited (BG) Misses Q4 EPS by 14c; offers outlook
Tweet
Share
E-mail
Get Alerts BG Hot Sheet
Price: $124.67 +5.02%
Revenue Growth %: +5.2%
Financial Fact:
Net loss (income) attributable to noncontrolling interest: -12M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Revenue Growth %: +5.2%
Financial Fact:
Net loss (income) attributable to noncontrolling interest: -12M
Today's EPS Names:
VIVO, BIOX, PMCB, More
Join SI Premium – FREE
Bunge Limited (NYSE: BG) reported Q4 EPS of $2.13, $0.14 worse than the analyst estimate of $2.27. Revenue for the quarter came in at $9.91 billion versus the consensus estimate of $13.73 billion.
GUIDANCE:
Bunge Limited sees FY2025 EPS of $7.75, versus the consensus of $8.81.
For earnings history and earnings-related data on Bunge Limited (BG) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Activist investor presses Xerox to review financial services arm - Bloomberg
- Akari Therapeutics to present ADC platform at five September conferences
- United Natural Foods (UNFI) Tops Q4 EPS by 8c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
